|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [668]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [668]
treatment of patients with schizophrenia. American Family Physician, 56, 1217–1220.
Salisbury, D. F., Bonner-Jackson, A., Griggs, C. B., Shenton, M. E., & McCarley, R. W. (2001). Mismatch negativity in schizophrenia: Does MMN amplitude decline with disease duration? Biological Psychiatry, 49 (Suppl.), 85S.
Salzman, C., Solomon, D., Miyawaki, E., Glassman, R., Rood, L., Flowers, E., et al. (1991). Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. Journal of Clinical Psychiatry, 52, 177–180.
Sanger, T. M., Lieberman, J. A., Tohen, M., Grundy, S., Beasley, C., Jr., & Tollefson, G. D. (1999). Olanzapine versus haloperidol treatment in first-episode psychosis. American Journal of Psychiatry, 156, 79–87.
Sartorius, N., Fleischhacker, W., Gjerris, A., Kern, U., Knapp, M., Leonard, B. E., et al. (2002). The usefulness and use of second-generation antipsychotic medications. Current Opinion in Psychiatry, 15, S1–S51.
Satterfield, J., Schell, A., Nicholar, T., Satterfield, B., & Freese, T. (1990). Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys. Biological Psychiatry, 28, 879–903.
Saykin, A. J., Shtasel, D. L., Gur, R. E., Kester, D. B., Mozley, L. H., Stafiniak, P., et al. (1994). Neuropsychological deficits in neuroleptic naive, first episode schizophrenic patients. Archives of General Psychiatry, 51, 124–131.
Schooler, N., Keith, S., Severe, J., Matthews, S., Bellack, A., Glick, I., et al. (1997). Relapse and rehospitalization during maintenance treatment of schizophrenia. Archives of General Psychiatry, 54, 453–463.
Schreiber, H., Stolz-Born, G., Heinrich, H., & Kornhuber, H. H. (1992). Attention, cognition, and motor perseveration in adolescents at genetic risk for schizophrenia and control subjects. Psychiatry Research, 44, 125–140.
Schwab, S. G., Knapp, M., Mondabon, S., Hallmayer, J., Borrmann-Hassenbach, M., Albus, M., et al. (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with link-age and in an additional sample of triad fami-lies. American Journal of Human Genetics, 72, 185–190.
Scottish Schizophrenia Research Group. (1987). The Scottish First Episode Schizophrenia Study. II. Treatment: Pimozide versus flupenthixol. The Scottish Schizophrenia Research Group. British Journal of Psychiatry, 150, 334–338.
Seeman, M. V. (1997). Psychopathology in women and men: Focus on female hormones. American Journal of Psychiatry, 154, 1641–1647.
Seidman, L. J., Faraone, S. V., Goldstein, J. M., Goodman, J. M., Kremen, W. S., Matsuda, G., et al. (1997). Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: A pilot MRI Study. American Journal of Medical Genetics, 74, 507–514.
Sernyak, M. J., Desai, R., Stolar, M., & Rosenheck, R. (2001). Impact of clozapine on completed suicide. American Journal of Psychiatry, 158, 931–937.
Sharma, S., & Lal, R. (1986). Minor physical anomalies in schizophrenia. International Journal of Neuroscience, 31, 138.
Shenton, M., Kikinis, R., Jolesz, F., Pollak, S., LeMay, M., Wible, C., et al. (1992). Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New England Journal of Medicine, 327, 604–612.
Shifman, S., Bronstein, M., Sternfeld, M., Pisante-Shalom, A., Lev-Lehman, E., Weizman, A., et al. (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 71, 1296–1302.
Silberg, J., Pickles, A., Rutter, M., Hewitt, J., Simonoff, E., Maes, H., et al. (1999). The influence of genetic factors and life stress on depression among adolescent girls. Archives of General Psychiatry, 56, 225–232.
end p.668
|
|
|
|
